Bellomic PCA in Laparoscopic Gynecologic Surgery

• Status: Recruiting
• Trial end date: 2023-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

In laparoscopic gynecological surgery, when intravenous patient-controlled analgesia (IV-PCA) device is used after surgery, the degree of postoperative side effects and pain control is compared when a combination of fentanyl and ketorolac is administered compared to when fentanyl alone is used.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Bundang Hospital
• Treatments: Fentanyl; Ketorolac

Criteria

Inclusion Criteria:

• American society of anesthesiology physical status 1 or 2

• Patients scheduled for gynecological laparoscopic surgery under general anesthesia

• Patients who applied for the use of IV-PCA after surgery

Exclusion Criteria:

• Patients with side effects of opioids

• Patients with hypersensitivity to aspirin or non-steroid anti-inflammatory drugs

• Patients with alcohol or drug dependence

• Patients with peptic ulcers, patients with gastrointestinal bleeding

• Patients with suspected cerebrovascular hemorrhage, organic disorders, or damage to the head related to increased intracranial pressure

• Symptoms of bronchial asthma or bronchospasm

• Patients with severe respiratory depression

• Moderate to severe renal impairment

• Patients with reduced blood volume or dehydration

• polyps in the nose

• angioedema

• Patients with or a history of the convulsive disease

• Patients for whom the use of neuromuscular blocking agents is contraindicated